CADASIL
26
11
13
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 26 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (26)
Long-term Prospective Study of Korean CADASIL Patients
Florida Cerebrovascular Disease Biorepository and Genomics Center
Imaging Study of Neurovascular Coupling in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL)
RAre, But Not aLone: a Large Italian Network to Empower the Impervious diaGNostic Pathway of Rare cerEbrovascular Diseases (ALIGNED)
Efficacy and Safety of Tocotrienols in CADASIL
Taiwan Associated Genetic and Nongenetic Small Vessel Disease
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL) Study
LeukoSEQ: Whole Genome Sequencing as a First-Line Diagnostic Tool for Leukodystrophies
The Myelin Disorders Biorepository Project
Neurologic Stem Cell Treatment Study
Generation of a Cellular Model of CADASIL From Skin Fibroblasts
Genotype, Clinical Features and Imaging of Neuroradiological Abnormalities in CADASIL
Development and Validation of a Functional MRI Biomarker of Cerebral Small Vessel Dysfunction in CADASIL
CERebrolysin In CADASIL
AusCADASIL: An Australian Cohort of CADASIL
Alzheimer's Autism and Cognitive Impairment Stem Cell Treatment Study
Adrenomedullin for CADASIL
CADASIL Registry Study
MRI Study of Blood-brain Barrier Function in CADASIL
Prognosis of Cerebral Small Vessel Disease